Genome-wide association Scan Identifies variants near matrix metalloproteinase (MMP) genes on chromosome 11q21-22 strongly associated with serum MMP-1 levels

Circulation: Cardiovascular Genetics

Volumn 2, Issue 4, 2009, Pages 329-337

  Cheng, Yu Ching ^a   Kao, Wen Hong L ^b   Mitchell, Braxton D ^a   O'Connell, Jeffrey R ^a   Shen, Haiqing ^a   McArdle, Patrick F ^a   Gibson, Quince ^a   Ryan, Kathleen A ^a   Shuldiner, Alan R ^a,c   Pollin, Toni I ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c BALTIMORE VA MEDICAL CENTER   (United States)

Author keywords

Epidemiology; Genetics; Metalloproteinases; Population

Indexed keywords

GENOMIC DNA; INTERSTITIAL COLLAGENASE; STROMELYSIN; MATRIX METALLOPROTEINASE;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHROMOSOME 11Q; CONTROLLED STUDY; DNA EXTRACTION; ENZYME BLOOD LEVEL; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC SCREENING; GENOTYPE; HERITABILITY; HUMAN; MALE; PRIORITY JOURNAL; QUALITY CONTROL; SINGLE NUCLEOTIDE POLYMORPHISM; AGE; BLOOD; CHROMOSOME 11; GENETICS; MIDDLE AGED; SEX DIFFERENCE;

ADULT; AGE FACTORS; CARDIOVASCULAR DISEASES; CHROMOSOMES, HUMAN, PAIR 11; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASES; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX FACTORS;

EID: 77449130846     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.108.834986     Document Type: Article

References (32)

1. Shah PK. Role of inflammation and metalloproteinases in plaque disruption and thrombosis. Vasc Med. 1998;3:199-206.
2. Shah PK, Galis ZS. Matrix metalloproteinase hypothesis of plaque rupture: players keep piling up but questions remain. Circulation. 2001; 104:1878-1880.
3. Jones CB, Sane DC, Herrington DM. Matrix metalloproteinases: a review of their structure and role in acute coronary syndrome. Cardiovasc Res. 2003;59:812-823.
4. Newby AC. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev. 2005;85:1-31.
5. Nikkari ST, O'Brien KD, Ferguson M, Hatsukami T, Welgus HG, Alpers CE, Clowes AW. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation. 1995;92:1393-1398.
6. Sukhova GK, Schonbeck U, Rabkin E, Schoen FJ, Poole AR, Billinghurst RC, Libby P. EviDence for increased collagenolysis by interstitial collagenases- 1 and -3 in vulnerable human atheromatous plaques. Circulation. 1999;99:2503-2509.
7. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix Degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994;94: 2493-2503.
8. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remoDeling and atherogenesis: the good, the bad, and the ugly. Circ Res. 2002;90: 251-262.
9. Galt SW, LinDemann S, Allen L, Medd DJ, Falk JM, McIntyre TM, Prescott SM, Kraiss LW, Zimmerman GA, Weyrich AS. OutsiDe-in signals Delivered by matrix metalloproteinase-1 regulate platelet function. Circ Res. 2002;90:1093-1099.
10. McNulty M, Mahmud A, Spiers P, Feely J. Collagen type-I DegraDation is related to arterial stiffness in hypertensive and normotensive subjects. J Hum Hypertens. 2006;20:867-873.
11. Ishikawa J, Kario K, Matsui Y, Shibasaki S, Morinari M, KaneDa R, HoshiDe S, Eguchi K, Hojo Y, ShimaDa K. Collagen metabolism in extracellular matrix may be involved in arterial stiffness in olDer hypertensive patients with left ventricular hypertrophy. Hypertens Res. 2005; 28:995-1001.
12. Zhang XW, Ge JB, Yang JM, Ge L, Wang NF, Gao Y, Li PZ, Pan H, Tong GX, Zhou L, Ye XH, Xu J. Relationship between hs-CRP, proMMP-1, TIMP-1 and coronary plaque morphology: intravascular ultrasound study. Chin Med J (Engl). 2006;119:1689-1694.
13. Hlatky MA, Ashley E, Quertermous T, Boothroyd DB, Ridker P, Southwick A, Myers RM, Iribarren C, Fortmann SP, Go AS. Matrix metalloproteinase circulating levels, genetic polymorphisms, and susceptibility to acute myocardial infarction among patients with coronary artery disease. Am Heart J. 2007;154:1043-1051.
14. Inoue T, Kato T, Takayanagi K, UchiDa T, Yaguchi I, Kamishirado H, Morooka S, Yoshimoto N. Circulating matrix metalloproteinase-1 and -3 in patients with an acute coronary syndrome. Am J Cardiol. 2003;92: 1461-1464.
15. Soejima H, Ogawa H, Sakamoto T, Miyamoto S, Kajiwara I, Kojima S, Hokamaki J, Sugiyama S, Yoshimura M, Suefuji H, Miyao Y, Fujimoto K, Miyagi H, Kishikawa H. Increased serum matrix metalloproteinase-1 concentration predicts adVanced left ventricular remoDeling in patients with acute myocardial infarction. Circ J. 2003;67:301-304.
16. Tziakas DN, Chalikias GK, Parissis JT, Hatzinikolaou EI, Papadopoulos ED, Tripsiannis GA, Papadopoulou EG, Tentes IK, Karas SM, Chatseras DI. Serum profiles of matrix metalloproteinases and their tissue inhibitor in patients with acute coronary syndromes. The effects of short-term atorvastatin administration. Int J Cardiol. 2004;94: 269-277.
17. Wu YW, Yang WS, Chen MF, Lee BC, Hung CS, Liu YC, Jeng JS, Huang PJ, Kao HL. High serum level of matrix metalloproteinase-1 and its rapid surge after intervention in patients with significant carotid atherosclerosis. J Formos Med Assoc. 2008;107:93-98.
18. Hojo Y, IkeDa U, Ueno S, Arakawa H, ShimaDa K. Expression of matrix metalloproteinases in patients with acute myocardial infarction. Jpn Circ J. 2001;65:71-75.
19. Lopez B, Gonzalez A, Querejeta R, Larman M, Diez J. Alterations in the pattern of collagen Deposition may contribute to the Deterioration of systolic function in hypertensive patients with heart failure. J Am Coll Cardiol. 2006;48:89-96.
20. Pearce E, Tregouet DA, Samnegard A, Morgan AR, Cox C, Hamsten A, Eriksson P, Ye S. Haplotype effect of the matrix metalloproteinase-1 gene on risk of myocardial infarction. Circ Res. 2005;97:1070-1076. (Pubitemid 41668921)
21. Ye S, Gale CR, Martyn CN. Variation in the matrix metalloproteinase-1 gene and risk of coronary heart disease. Eur Heart J. 2003;24: 1668-1671.
22. Nojiri T, Morita H, Imai Y, Maemura K, Ohno M, Ogasawara K, Aizawa T, Saito A, Hayashi D, Hirata Y, Sugiyama T, Yamazaki T, Nagai R. Genetic variations of matrix metalloproteinase-1 and -3 promoter regions and their associations with susceptibility to myocardial infarction in Japanese. Int J Cardiol. 2003;92:181-186.
23. Horne BD, Camp NJ, Carlquist JF, Muhlestein JB, Kolek MJ, Nicholas ZP, AnDerson JL. Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease. Am Heart J. 2007;154:751-758.
24. Han Y, Wu Z, Zhang X, Yan C, Xi S, Yang Y, Pei F, Kang J. Impact of matrix metalloproteinase-1 gene variations on risk of acute coronary syndrome. Coron Artery Dis. 2008;19:227-230.
25. Rutter JL, Mitchell TI, Buttice G, Meyers J, Gusella JF, Ozelius LJ, Brinckerhoff CE. A single nucleotiDe polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res. 1998;58:5321-5325.
26. Mitchell BD, McArdle PF, Shen H, Rampersaud E, Pollin TI, Bielak LF, Jaquish C, Douglas JA, Roy-Gagnon MH, Sack P, Naglieri R, Hines S, Horenstein RB, Chang YP, Post W, Ryan KA, Brereton NH, Pakyz RE, Sorkin J, Damcott CM, O'Connell JR, Mangano C, Corretti M, Vogel R, Herzog W, Weir MR, Peyser PA, Shuldiner AR. The genetic response to short-term interventions affecting cardiovascular function: rationale and Design of the Heredity and Phenotype Intervention (HAPI) Heart Study. Am Heart J. 2008;155:823-828.
27. Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet. 1998;62:1198-1211.
28. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263-265.
29. Morgan AR, Rerkasem K, Gallagher PJ, Zhang B, Morris GE, CalDer PC, Grimble RF, Eriksson P, McPheat WL, Shearman CP, Ye S. Differences in matrix metalloproteinase-1 and matrix metalloproteinase-12 transcript levels among carotid atherosclerotic plaques with different histopathological characteristics. Stroke. 2004;35:1310-1315.
30. Galis ZS, Sukhova GK, Kranzhofer R, Clark S, Libby P. Macrophage foam cells from experimental atheroma constitutively produce matrixDegrading proteinases. Proc Natl Acad Sci USA. 1995;92:402-406.
31. Axisa B, Loftus IM, Naylor AR, GooDall S, Jones L, Bell PR, Thompson MM. Prospective, randomized, double-blind trial investigating the effect of doxycycline on matrix metalloproteinase expression within atherosclerotic carotid plaques. Stroke. 2002;33:2858-2864.
32. Guo LJ, Luo XH, Wu XP, Shan PF, Zhang H, Cao XZ, Xie H, Liao EY. Serum concentrations of MMP-1, MMP-2, and TIMP-1 in Chinese women: age-related changes, and the relationships with bone biochemical markers, bone mineral Density. Clinica Chimica Acta. 2006;371:137-142. (Pubitemid 44162908)